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Abstract 
Background: Diabetic retinopathy has long been regarded as the commonest 
preventable cause of blindness in the working age population. Consistent annual 
screening for treatable retinopathy would be expected to decrease the incidence of 
new blindness.  
Methods: We collated the causes of blindness for a 5 year period between 2001- 2005 
for the 16 – 64 year age group in a district which had operated systematic retinal 
screening in diabetes since 1986.   
Results: Diabetic retinopathy was found to be the second commonest cause of 
blindness, with optic atrophy being the commonest cause in Newcastle District. This 
differs from national data showing diabetic retinopathy to be the commonest cause. 
Diabetic retinopathy was also the second commonest cause of partial sightedness 
registrations with stroke being the commonest cause. Overall, stroke disease 
accounted for 16.2 % and diabetes for 15.4 % of registrations. The annual incidence 
of blindness was 0.22 per 1000 with diabetes and partial sightedness was 0.43 per 
1000 with diabetes.  
Conclusions: Systematic annual screening for retinopathy demotes diabetes from 
being the commonest cause of blindness in the working age population.  
Keywords: Diabetic retinopathy, blindness, retinal screening, maculopathy, 
proliferative retinopathy 
Abbreviations: PS partial sightedness, UKPDS United Kingdom Prospective Diabetes 
Study 
Introduction 
 
Diabetic retinopathy has long been recognised as the commonest cause of 
blindness in the working age population (1-5). A recent report showed that all three 
leading causes of blindness - age related macular degeneration, diabetic retinopathy 
and glaucoma - to be increasing (6). Loss of vision at any age is catastrophic, but in 
the working age range has particularly devastating personal, family and societal 
consequences. Given that the commonest underlying reason for diabetes related visual 
loss aged 16-64 years is proliferative retinopathy, and that therapy for this is almost 
completely effective if given at an early stage it would be expected that screening 
should markedly decrease rates of blindness in this age range (7). However, the most 
recent figures for England and Wales suggest that there has been little change since 
1990 (8) and this could relate to incomplete screening coverage over this period (9) 
Visual impairment due to diabetes does not become symptomatic until proliferative 
retinopathy or macular disease have become advanced, and an effective annual 
screening programme would be expected to identify treatable retinopathy at a 
preventable stage. The retinal screening programme Newcastle District commenced in 
1986 and has achieved near comprehensive population coverage since 1996 (11). The 
St Vincent Declaration set out a target of reduction in new blindness due to diabetes 
by one third. Our aim was to determine the prevalence of significant visual 
impairment related to diabetes and other causes in the 16- 64 years age group of this 
district between 2001 and 2005. 
 
 
 
Methodology 
The Newcastle Diabetes Centre provides retinal screening for Newcastle 
district (population 270000) using two static retinal cameras for patients attending for 
specialist care and patients whose diabetes is managed in the community. The 
programme commenced in 1986 using a mobile unit (10), and achieved coverage of 
all people registered as having diabetes by 1998, when screening became deliverable 
from a central Diabetes Centre. Since then, annual population coverage in Newcastle 
District has been consistently over 80%. The original Polaroid photography was 
replaced by digital retinal imaging in 2000. Screening is performed by trained retinal 
screeners who measure visual acuity, instill tropicamide eye drops, carry out retinal 
photography, assess the images and explain the findings to each individual patient. 
Quality assurance is continuously monitored (11). Ungradeable images were defined 
as those in which the second order of arterioles were unclear or in which less than 
75% of the retina was visible, and patients with ungradeable images (5.0% of all 
screened)  were referred for ophthalmological examination in view of the previous 
observation of a high rate of sight threatening retinopathy in this group (12). The 
standards used over the period reported in this paper originally contributed to the 
current UK nationally agreed standards (13).  
The Newcastle Ophthalmology Department deals with all ophthalmological 
referrals from Newcastle as well as the surrounding districts.  
In the UK certifiable blindness is defined as: 
1. Visual acuity of less than 3/60 with a full visual field.  
2. Visual acuity  better than 3/60 but below 6/60  with a very restricted visual field 
 
 
Partial sightedness is defined as: 
1. Visual acuity of 3/60 to 6/60 with a full field of vision.  
2. Visual acuity of up to 6/24 with a moderate restriction of field of vision or with 
opacities in the media or aphakia 
3. Visual acuity of 6/18 or better with a gross visual field defect as with hemianopia, 
retinitis pigmentosa or glaucoma. 
All patients aged 16-64 registered with blindness or partial sightedness during the 
period January 2001 to December 2005, were identified from the records of the Royal 
National Institute for the Blind Liaison Office. This office, situated in the Newcastle 
Ophthalmology Department, has maintained records of all those registered visually 
impaired since 1998, and the completeness of collection of this information on people 
with diabetes has been verified by cross-checking of visual acuity data in the clinical 
diabetes records (14).   Details of type and duration of diabetes, and other medical 
conditions was obtained from Diabetes clinical records. Information on type of 
retinopathy & treatment was collated from the Ophthalmology Department clinical 
records. Only those patients with a Newcastle District postal code were identified 
included to allow calculation of rates of visual loss in a defined population. 
 
Results     
A total of 130 registrations were recorded over the 5 year period. Blindness 
accounted for 56 of these registrations. Seven patients with diabetic retinopathy were 
registered blind and 13 registered partially sighted. Optic atrophy was the commonest 
cause of blindness (10 patients), with diabetic retinopathy being the second 
commonest cause. Of the 74 patients registered partially sighted, stroke was the 
commonest cause (16 patients), with diabetic retinopathy being the second 
commonest cause (13 patients) (Table 1). 
When all registrations were combined together, stroke was the commonest 
cause for any registration (21 patients) with diabetes being the second commonest 
cause (20 patients). Other causes were optic atrophy (18), hereditary retinal disorders 
(9), macular degeneration (12), glaucoma (12), myopic degeneration (10), cataract 
(6), neurodegenerative disorder (5), neoplasia (2) and uveitis (2). Amongst people 
with type 1 diabetes (n=5) there was 2 registered blind and 3 partially sighted. 
Amongst people with type 2 diabetes (n=15) there were 5 registered blind and 10 
partially sighted. Mean age of registration in all patients was 55 years for blindness 
and 52 years for partial sightedness. A lag period between 3 to 5.5 years was noted 
between referral and registration. All patients underwent laser therapy within a few 
months of referral to ophthalmology service. In type 1 diabetes the primary reason for 
registration was proliferative retinopathy (3 patients) and maculopathy (2 patients). In 
comparison, in type 2 diabetes proliferative retinopathy accounted for 6 patients and 
macular oedema 9 patients. The similar overall prevalence of proliferative retinopathy 
to macular disease in the age group studied may reflect the considerably better 
response of the former to laser therapy (additional refs A & B).  
The annual incidence of blindness in Newcastle district in the working age 
population was calculated knowing the population aged 15- 64 years for Newcastle 
District (172,653 from 2001 Census) and the age specific prevalence of diabetes in the 
UK (3.5 %) (18). Of the population at risk of visual loss from diabetes (6,043), 7 
patients became blind during the 5 year period. Hence the annual incidence of 
blindness was 0.22 per 1000 with diabetes. 13 patients were registered partially 
sighted, equivalent to an annual incidence of 0.43 per 1000 with diabetes. 
 Discussion 
 
After 15-20 years of screening for treatable diabetic retinopathy, diabetes was 
found to be no longer the commonest cause of blindness in the working age 
population. In Newcastle District over the 5 year period from 2001- 2005, the 
commonest cause of blindness registration for this age group was optic atrophy. 
Diabetic retinopathy was the second commonest cause. The commonest cause for 
partial sightedness was stroke disease, with diabetes again being second commonest. 
When all registrations were considered together, stroke disease remained the 
commonest cause and diabetes was the second commonest cause. A low annual 
registration rate was noted for blindness and partial sightedness (0.22 and 0.45 per 
1000 patients per year with diabetes respectively). Although these data are based on 
the voluntary blind registration process, the completeness of this information was 
verified by cross-checking of visual acuity data with the clinical diabetes records in 
the Newcastle Diabetes Centre.  
The best comparable data for the 16-64 year age group are from UK national 
data on blindness registrations relating to 1900 and 1999-2000 (5; 8). In 1990, 
diabetes was by far the leading cause of blindness and this had not changed in 1999-
2000. Our observations on Newcastle are very different, with blindness due to 
diabetes accounting for only 12.1 % of registrations. Over the same period, rates of 
new blindness due to glaucoma fell, and rates were similar for 1999-2000 for the UK 
and 2000-2005 for Newcastle. As rates of optic atrophy were observed to be fairly 
constant and would not be expected to change over this period, the ratio of blindness 
due to diabetes or due to optic atrophy is of interest. The England and Wales national 
data show ratios of  1.3:1  (11.9: 9.4)  and 1.7: 1 (17.7: 10.1) in 1990 and 1999-2000 
respectively, suggesting no major change in blindness due to diabetes over the 10 year 
period. However, in Newcastle District the ratio was found to be 0.78:1 (12.1:15.5). 
The fall in incidence of blindness associated with a systematic retinal screening 
programme which we have observed is consistent with a previous report ref 2.  
programme (2).   
A low registration rate was noted for blindness and partial sightedness namely 
0.22 and 0.45 per year per 1000 patients with diabetes respectively. There are no 
previous reports of incidence in working age population to compare with the present 
results and the median age of blindness registration in working age population has not 
previously been reported. However, in Newcastle, in 1985, there were at least 6 
patients < 25 years of age registered blind.  Based on the current data, median age of 
registration in this age group is 53 years.   
The factors contributing to the fall in incidence of new significant visual 
impairment must be considered. Both better treatment of diabetes and effective 
screening coupled with appropriate laser treatment could impact upon the data. Better 
blood glucose and blood pressure control can delay the rate of progression of diabetic 
retinopathy (UKPDS) with both onset and progression to sight threatening retinopathy 
being decreased (DCCT) (15; 16). However, comparative data show no major 
differences in HbA1c and blood pressure in national data compared with our own (17) 
and there is no reason to suggest that differences in clinical management of diabetes 
could account for the greater fall in rates of diabetic blindness in Newcastle. On the 
other hand, retinal screening in Newcastle has been carried out year-on-year with 
good population coverage and quality assurance (ref 11). Population coverage with 
retinal screening has been limited in the UK as a whole (ref 9). Retinal screening in 
coordinated partnership with timely application of laser therapy is likely to be a more 
potent factor underlying the lower rates of visual impairment observed in this study.   
It is notable that stroke disease accounted for such high partial sightedness 
registration rates. All cases were all due to significant field defects leading to visual 
disability and reflect a changing attitude to partial sightness registration. With the 
recent UK change in details required for registration of blindness or partial 
sightedness it has become easier to register this category based on field defects (8).  
In summary, diabetes is no longer the commonest cause of preventable 
blindness and partial sightedness in working age population in a district which has 
had a long established comprehensive screening and treatment programme for all 
people with diabetes.  There has been a major change in age of onset of blindness due 
to diabetes. This report demonstrates that the visual preservation objectives of the 
St.Vincent’s Declaration are achievable.   
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Table 1: Causes of blindness and partial sightedness registrations 
 No. of 
Blind 
% of 
blind 
No. of 
PS 
% 
PS 
Total 
Registered 
% 
Registered 
Optic Atrophy 10 17.9 8 10.8 18 13.8 
Diabetic retinopathy 7 12.5 13 17.6 20 15.4 
Hereditary retinal disorders 7 12.5 2 2.7 9               6.9 
Cerebrovascular Disease 5 9 16 21.6                21 16.2 
Macular Degeneration 5 9 7 9.5 12                9.2 
Glaucoma 3 5.4 9 12.2 12 9.2 
Myopic Degeneration 3 5.4 7 9.5 10                7.7 
Cataract 3 5.4 3 4.1 6               4.6 
Neurodegenerative Disorder 4 7.1 1 1.4 5               3.8 
Corneal scarring 3 5.4 2 2.7 5 3.8 
Neoplasia 1 1.8 1 1.4 2 1.5 
Uveitis 1 1.8 1 1.4 2 1.5 
Ambylopia with corneal 
scarring in the other eye 
1 1.8   1 0.8 
Ambylopia with epiretinal 
membrane in the other eye 
  1 1.4 1 0.8 
Vigabatrin macular toxicity 1 1.8   1 0.8 
Quinine toxicity  1 1.8   1 0.8 
Macular scarring 1 1.8 1 1.4 2 1.5 
Retinal necrosis syndrome   1 1.4 1 0.8 
Hypertensive retinopathy   1 1.4 1 0.8 
Total 56 100 74 100 130 100 
 Table 2: Characteristics of diabetes patients registered blind or partially sighted  
 Patients 
(number) 
Sex 
(M/F) 
Mean 
age 
(years) 
Duration of 
diabetes  
(years) 
Referral to 
registration 
(years) 
Type 1 diabetes 
Blind 
2 1 F 
1M 
56.5  51  4 
Type 1 diabetes  
PS 
3 2F 
1M 
50.6 22 (21- 23) 5 (3-7) 
All type 1  5 5    
Type 2 diabetes 
PS 
10 8F 
 
2M 
53.6 10.5 (0-15) 3 (0-5) 
Type 2 diabetes 
blind 
5 3F 
2M 
66.25 12 (3- 19)   5.5 (3- 8) 
All type 2  15 15    
 
 
 
 
 
 
 
 
 
